SCHEMBL19976929

SCHEMBL19976929

CC(C)(C)N/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2ncccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
GRM4 Q14833 3/20 0.35
AURKA O14965 1/20 0.35
AURKB Q96GD4 1/20 0.35
VNN1 O95497 2/20 0.34
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CHRND Q07001 1/20 0.34
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
CES1 P23141 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976730 0.86 HDAC6 (0.41) AURKBDYRK1AMAPK1HDAC6JAK2
SCHEMBL19976852 0.85 HDAC6 (0.40) RIPK1AURKAAURKBTRPV1HDAC6
SCHEMBL19976801 0.85 TRPA1 (0.37) AURKBCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL19976804 0.82 TRPA1 (0.37) AURKAAURKBCHRNA1CHRNGCHRNB1
SCHEMBL19976765 0.82 NTRK1 (0.41) AURKAAURKBDYRK1AHDAC6JAK2
SCHEMBL19976726 0.80 ABL1 (0.41) RIPK1AURKAAURKBCHRNA1CHRNG
SCHEMBL19976725 0.79 GSK3B (0.52) DYRK1AMAPK1HDAC6
SCHEMBL19976736 0.79 MAP2K4 (0.44) AURKAAURKBDYRK1AMAPK1HDAC6
SCHEMBL16752857 0.78 CHRNA1 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL16752855 0.78 CHRNA1 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed